Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
about
Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathwaysCancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancerMacrophage-tumor cell interactions regulate the function of nitric oxideERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinomaDifferential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control studyEndoplasmic reticulum stress pathway PERK-eIF2α confers radioresistance in oropharyngeal carcinoma by activating NF-κB.Low-level laser irradiation, cyclooxygenase-2 (COX-2) expression and necrosis of random skin flaps in rats.Up-regulation of PIK3CA promotes metastasis in gastric carcinoma.Crocetin downregulates the proinflammatory cytokines in methylcholanthrene-induced rodent tumor model and inhibits COX-2 expression in cervical cancer cells.Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway.HGF/MET signaling promotes glioma growth via up-regulation of Cox-2 expression and PGE2 productionOverexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.P27/SKP-2 histochemical profile is relevant to malignant salivary gland tumors (MST) histogenesis and tumor grade.STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and TransformationBlood-brain barrier dysfunction in epileptogenesis of the temporal lobeIGFBP2 potentiates nuclear EGFR-STAT3 signaling.Molecular biology of human gliomas.Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.Targeting nitric oxide for cancer therapy.Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.Is HCMV a tumor promoter?Targets for therapy in ependymoma.Cyclooxygenase-2 in glioblastoma multiforme.Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma.Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration.Intratumoral hemorrhage-related differences in the expression of vascular endothelial growth factor, basic fibroblast growth factor and thioredoxin reductase 1 in human glioblastoma.Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.Chronic hydrocephalus-induced hypoxia: increased expression of VEGFR-2+ and blood vessel density in hippocampus.Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours.Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.Disparities in Brain Cancer in the United States: A Literature Review of Gliomas.GFAPδ/GFAPα ratio directs astrocytoma gene expression towards a more malignant profile.Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab.
P2860
Q26821895-9144A6D0-63A4-42A1-997D-101E0BA9B3A1Q28273809-5CD89123-624C-4768-AEBB-1CB904867362Q28384490-2637C3A1-57B3-4151-92FD-2CA347FCD2C9Q28390293-CB420ECC-0D15-46F7-92F6-F47E54762686Q30428613-44F1D9ED-AA77-4586-AD26-441EF4A5D016Q30817240-C115F673-9056-4033-AAC1-B9CAE59EAC6BQ33873153-799C8117-6EAE-4018-8F7D-9D162725C260Q34053061-9A4C7050-864E-452B-8679-17A696CA9C7CQ34213783-68A25054-4F0F-497A-83CD-12C6D9F02437Q35271285-8E8CFAB1-C426-451F-92BC-5835F5323C09Q35632717-528D6266-6553-406E-BB34-F56A2DE34D9FQ35740986-35486F90-0068-43E0-890C-E9CF92C5FEE0Q35756369-2F3C9960-D068-4ED3-8498-29B6790B8016Q36016145-CC602CCA-7018-4997-A8A5-1D6029170CE5Q36130808-4236A1B9-0897-4B5A-B8D2-EE36F9ED17A5Q36168832-03E87431-7ADD-4B5B-9778-1A32E1488ACFQ36189855-CF76C366-F836-427A-AA2F-3A964F60A31EQ36478640-0FA9F5DE-963D-4E82-99B0-92782567FC1AQ36642753-5DD2A8F0-6AED-49AB-A0A7-CB6DC25A9E8DQ36709690-CDD0940F-3E3E-4313-BCDF-AABC72565E86Q37036925-1459AE77-4531-4472-A38A-9A541E0E81B6Q37037859-6FCDBE07-9014-415A-8598-F3D7164E2CE5Q37805181-3EE035B9-26B0-41AE-8BBE-6C8212F19D70Q37858907-2299EFC8-658E-43CA-B6FC-34CAE3CC9AE5Q38969912-A98C9558-B4F7-45D0-B409-2A3C1939CC3DQ39062141-31BE57A6-A1E8-4CDD-BDF8-1D2F1D6200D5Q39276818-A45D22C2-BE52-4BD5-B2DD-44F045DBEFC6Q39470558-99994267-6B7E-4895-84EC-5A55BEEA4806Q39559394-3B44C06D-B915-445C-8C5F-ED61B54B4161Q40087518-6F44F20A-3E98-43DC-847D-B7FCE1074263Q41193937-72001A47-84BE-476D-91D9-F1532047C383Q41541275-0AE21D78-0898-4432-99CA-99D26FCB0871Q42378300-AAFAE057-132F-4668-9289-E3C38542423EQ43155654-C773DEE4-48A5-4569-A55D-F2760CD06D1EQ46230407-A23AE397-FA54-40F2-A365-3EFA7F821386Q46536800-C62E12E4-F9F9-4778-BC01-47BBE8C6AEC6Q46817843-A9618301-DE1E-4742-819C-170B5F190D4BQ46912145-6CA9F545-02D8-458F-9E1C-E6230644680EQ47103846-B0BF6EAE-8CE6-4CB6-A47C-35F0BD013B44Q47136533-F1551813-9D77-4B9B-9F47-129D1FEA7926
P2860
Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@en
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@nl
type
label
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@en
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@nl
prefLabel
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@en
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@nl
P1476
Cyclooxygenase-2 and inducible ...... s and prognostic significance.
@en
P2093
Atsuko Hara
Isao Okayasu
P2888
P356
10.1007/S00401-004-0860-0
P577
2004-04-16T00:00:00Z